Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kwame Osei
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Living Beings
Concepts & Ideas
Anatomy
Geographic Areas
Sign-in to see full Profile
Network (preview)
25
Schuster, Dara
22
Gaillard, Trudy
16
O'Dorisio, Thomas
11
Schuster, Dara
8
Ferguson, Ronald
7
Amoah, Albert
6
Henry, Mitchell
6
Rhinesmith, Scott
6
Tesi, RJ
5
Sparks, Elizabeth
5
Wooley, Charles
5
Owusu, Samuel
5
Boudoulas, Harisios
5
Falko, James
4
Stakos, Dimitrios
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kwame Osei (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Mount David L; Feeney Patricia; Fabricatore Anthony N; Coday Mace; Bahnson Judy; Byington Robert; Phelan Suzanne; Wilmoth Sharon; Knowler William C; Hramiak Irene; Osei Kwame; Sweeney Mary Ellen; Espeland Mark A;
Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials.
Clinical trials (London, England) 2009;6(5):416-29.
-
2009: Norris Leigh E; Collene Angela L; Asp Michelle L; Hsu Jason C; Liu Li-Fen; Richardson Julia R; Li Dongmei; Bell Doris; Osei Kwame; Jackson Rebecca D; Belury Martha A
Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus.
The American journal of clinical nutrition 2009;90(3):468-76.
-
2008: Rajab Amer; Buss Jill; Diakoff Elizabeth; Hadley Gregg A; Osei Kwame; Ferguson Ronald M
Comparison of the portal vein and kidney subcapsule as sites for primate islet autotransplantation.
Cell transplantation 2008;17(9):1015-23.
-
2007: Gaillard Trudy R; Sherman W Michael; Devor Steven T; Kirby Timothy E; Osei Kwame
Importance of aerobic fitness in cardiovascular risks in sedentary overweight and obese African-American women.
Nursing research 2007;56(6):407-15.
-
2007: Stakos Dimitrios A; Schuster Dara P; Sparks Elizabeth A; Meis Sophia Boudoulas; Wooley Charles F; Osei Kwame; Boudoulas Harisios
Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance.
European journal of endocrinology / European Federation of Endocrine Societies 2007;157(1):63-8.
-
2007: Bonds Denise E; Kurashige Ella Mae; Bergenstal Richard; Brillon David; Domanski Michael; Felicetta James V; Fonseca Vivian A; Hall Kathleen; Hramiak Irene; Miller Michael E; Osei Kwame; Simons-Morton Denise G;
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
The American journal of cardiology 2007;99(12A):80i-89i.
-
2007: Osei Kwame; Gaillard Trudy; Schuster Dara
Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
Metabolism: clinical and experimental 2007;56(1):24-9.
-
2007: Schuster Dara P; Gaillard Trudy; Osei Kwame
The cardiometabolic syndrome in persons of the African diaspora: challenges and opportunities.
Journal of the cardiometabolic syndrome 2007;2(4):260-6.
-
2006: Jain Rajeev; Osei Kwame; Kupfer Stuart; Perez Alfonso T; Zhang Jeff
Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.
Pharmacotherapy 2006;26(10):1388-95.
-
2006: Meis Sophia Boudoulas; Schuster Dara; Gaillard Trudy; Osei Kwame
Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Ethnicity & disease 2006;16(4):830-6.
-
2005: Stakos Dimitrios A; Schuster Dara P; Sparks Elizabeth A; Wooley Charles F; Osei Kwame; Boudoulas Harisios
Cardiovascular effects of type 1 diabetes mellitus in children.
Angiology 2005;56(3):311-7.
-
2005: Stakos D A; Schuster D P; Sparks E A; Wooley C F; Osei K; Boudoulas H
Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study.
Heart (British Cardiac Society) 2005;91(5):589-94.
-
2005: Osei Kwame; Gaillard Trudy; Schuster Dara
Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
Obesity research 2005;13(1):179-85.
-
2005: Osei Kwame; Gaillard Trudy; Cook Charles; Kaplow June; Bullock Matthew; Schuster Dara
Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone.
Ethnicity & disease 2005;15(4):641-8.
-
2004: Osei Kwame; Gaillard Trudy; Kaplow June; Bullock Matthew; Schuster Dara
Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.
Metabolism: clinical and experimental 2004;53(12):1552-7.
-
2004: Schuster Dara; Gaillard Trudy; Rhinesmith Scott; Habash Diane; Osei Kuame
Impact of metformin on glucose metabolism in nondiabetic, obese African Americans: a placebo-controlled, 24-month randomized study.
Diabetes care 2004;27(11):2768-9.
-
2004: Osei Kwame; Rhinesmith Scott; Gaillard Trudy; Schuster Dara
Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.
Diabetes care 2004;27(6):1439-46.
-
2004: Saad Mohammed F; Greco Susan; Osei Kwame; Lewin Andrew J; Edwards Christopher; Nunez Margarita; Reinhardt Rickey R;
Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.
Diabetes care 2004;27(6):1324-9.
-
2004: Osei Kwame; Rhinesmith Scott; Gaillard Trudy; Schuster Dara
Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.
Metabolism: clinical and experimental 2004;53(4):414-22.
-
2003: Osei Kwame; Rhinesmith Scott; Gaillard Trudy; Schuster Dara
Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?
The Journal of clinical endocrinology and metabolism 2003;88(10):4596-601.
-
2003: Schuster D; Gaillard T; Rhinesmith S; Habash D; Osei K
The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study.
Metabolism: clinical and experimental 2003;52(9):1211-7.
-
2003: Amoah A G B; Schuster D P; Gaillard T; Osei K
Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians.
Diabetologia 2003;46(7):949-55.
-
2003: Osei Kwame; Rhinesmith Scott; Gaillard Trudy; Schuster Dara
Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.
Metabolism: clinical and experimental 2003;52(5):565-72.
-
2003: Stakos Dimitrios A; Schuster Dara P; Sparks Elizabeth A; Wooley Charles F; Osei Kwame; Boudoulas Harisios
Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
Journal of cardiology 2003;41(4):183-90.
-
2003: Osei Kwame; Schuster Dara P; Amoah Albert G B; Owusu Samuel K
Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations.
Journal of cardiovascular risk 2003;10(2):85-96.
-
2003: Osei Kwame
Global epidemic of type 2 diabetes: implications for developing countries.
Ethnicity & disease 2003;13(2 Suppl 2):S102-6.
-
2002: Cosio Fernando G; Pesavento Todd E; Kim Sunny; Osei Kwame; Henry Mitchell; Ferguson Ronald M
Patient survival after renal transplantation: IV. Impact of post-transplant diabetes.
Kidney international 2002;62(4):1440-6.
-
2002: Amoah Albert G B; Owusu Samuel K; Schuster Dara P; Osei Kwame
Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2002;92(5):377-84.
-
2002: Amoah Albert G B; Schuster Dara P; Gaillard Trudy; Osei Kwame
Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Ethnicity & disease 2002;12(4):S3-10-7.
-
2001: Kallaras K; Sparks E A; Schuster D P; Osei K; Wooley C F; Boudoulas H
Cardiovascular effects of aging. Interrelationships of aortic, left ventricular, and left atrial function.
Herz 2001;26(2):129-39.
-
2001: Cosio F G; Pesavento T E; Osei K; Henry M L; Ferguson R M
Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.
Kidney international 2001;59(2):732-7.
-
2001: Amoah A G; Owusu S K; Ayittey O M; Schuster D P; Osei K
Minimal model analyses of beta cell secretion, insulin sensitivity and glucose effectiveness in glucose tolerant, non-diabetic first-degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects.
Ethnicity & disease 2001;11(2):201-10.
-
1999: Osei K; Gaillard T; Schuster D P
Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients.
Diabetes care 1999;22(9):1594-6.
-
1999: Osei K; Gaillard T; Schuster D P
Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance.
Diabetes care 1999;22(9):1588-90.
-
1999: Osei K
Insulin resistance and systemic hypertension.
The American journal of cardiology 1999;84(1A):33J-36J.
-
1999: Osei K
Metabolic consequences of the West African diaspora: lessons from the thrifty gene.
The Journal of laboratory and clinical medicine 1999;133(2):98-111.
-
1998: Osei K
Post-transplantation hypoglycaemia in type 1 diabetic pancreas allograft recipients.
Acta diabetologica 1998;35(4):176-82.
-
1998: Schuster D P; Kien C L; Osei K
Differential impact of obesity on glucose metabolism in black and white American adolescents.
The American journal of the medical sciences 1998;316(6):361-7.
-
1998: Amoah A G; Owusu S K; Saunders J T; Fang W L; Asare H A; Pastors J G; Sanborn C; Barrett E J; Woode M K; Osei K
Facilities and resources for diabetes care at regional health facilities in southern Ghana.
Diabetes research and clinical practice 1998;42(2):123-30.
-
1998: Osei K; Gaillard T R; Schuster D P
History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes.
Diabetes care 1998;21(8):1250-7.
-
1998: Gaillard T R; Schuster D P; Osei K
Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.
Ethnicity & disease 1998;8(3):319-30.
-
1997: Gaillard T R; Schuster D P; Bossetti B M; Green P A; Osei K
Do sociodemographics and economic status predict risks for type II diabetes in African Americans?
The Diabetes educator 1997;23(3):294-300.
-
1997: Gaillard T R; Schuster D P; Bossetti B M; Green P A; Osei K
The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
Diabetes care 1997;20(5):745-52.
-
1997: Osei K; Gaillard T; Schuster D P
Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
Diabetes care 1997;20(3):396-404.
-
1997: Osei K; Schuster D P; Owusu S K; Amoah A G
Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African ancestry and white Americans.
Metabolism: clinical and experimental 1997;46(1):53-8.
-
1996: Osei K; Schuster D P
Effects of race and ethnicity on insulin sensitivity, blood pressure, and heart rate in three ethnic populations: comparative studies in African-Americans, African immigrants (Ghanaians), and white Americans using ambulatory blood pressure monitoring.
American journal of hypertension 1996;9(12 Pt 1):1157-64.
-
1996: Schuster D P; Osei K; Zipf W B
Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
Metabolism: clinical and experimental 1996;45(12):1514-20.
-
1996: Osei K; Schuster D P
Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants.
The American journal of the medical sciences 1996;311(3):113-21.
-
1995: Osei K; Schuster D P
Effects of heparin-induced non-esterified free fatty acid on minimal model-derived insulin sensitivity in individuals with varying degrees of glucose intolerance.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(10):911-5.
-
1995: Osei K; Schuster D P
Metabolic characteristics of African descendants: a comparative study of African-Americans and Ghanaian immigrants using minimal model analysis.
Diabetologia 1995;38(9):1103-9.
-
1994: Osei K; Cottrell D A
Minimal model analyses of insulin sensitivity and glucose-dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes.
European journal of clinical investigation 1994;24(12):843-50.
-
1994: Landon M B; Osei K; Platt M; O'Dorisio T; Samuels P; Gabbe S G
The differential effects of body fat distribution on insulin and glucose metabolism during pregnancy.
American journal of obstetrics and gynecology 1994;171(4):875-84.
-
1994: Osei K; Schuster D P
Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans.
Diabetic medicine : a journal of the British Diabetic Association 1994;11(8):755-62.
-
1994: Schuster D; O'Dorisio T M; Osei K
Case report: defective beta and alpha cell regulation in patients with hyperinsulinemia and acanthosis nigricans.
The American journal of the medical sciences 1994;307(5):342-5.
-
1994: Osei K; Henry M; Ferguson R
Differential effects of systemic insulin delivery and prednisone on tissue glucose and insulin sensitivity in insulin-dependent diabetes mellitus pancreas recipients.
Transplantation proceedings 1994;26(2):480-2.
-
1993: Osei K; Cottrell D A; Adenuwon C A; Ezenwaka E C; Akanji A O; O'Dorisio T M
Serum insulin and glucose concentrations in people at risk for type II diabetes. A comparative study of African Americans and Nigerians.
Diabetes care 1993;16(10):1367-75.
-
1993: Ezenwaka C E; Akanji A O; Osei K; Adejuwon C A; O'Dorisio T M; Cottrell D A; Akinlade K S
Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus.
Diabetes research and clinical practice 1993;20(3):175-81.
-
1992: Osei K
The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
Diabetes research and clinical practice 1992;17(3):169-82.
-
1992: Osei K; Cottrell D A; Henry M L; Tesi R J; Ferguson R M; O'Dorisio T M
Minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in type 1 (insulin-dependent) diabetic pancreas allograft recipients.
Diabetologia 1992;35(7):676-80.
-
1992: Osei K; Cottrell D A; Harris B
Differences in basal and poststimulation glucose homeostasis in nondiabetic first degree relatives of black and white patients with type 2 diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1992;75(1):82-6.
-
1992: Cottrell D A; Henry M L; O'Dorisio T M; Tesi R J; Ferguson R M; Osei K
Sequential metabolic studies of pancreas allograft function in type 1 diabetic recipients.
Diabetic medicine : a journal of the British Diabetic Association 1992;9(5):438-43.
-
1992: Osei K; Cottrell D A; Henry M L; Tesi R J; Ferguson R M; O'Dorisio T M
Insulin insensitivity and glucose effectiveness in type I diabetic allograft pancreas recipients.
Transplantation proceedings 1992;24(3):828-30.
-
1992: Barone G W; Henry M L; Elkhammas E A; Osei K; Tesi R J; Ferguson R M
Pancreatic exocrine "burnout" following pancreas transplantation.
Transplantation proceedings 1992;24(3):831-2.
-
1991: Cottrell D A; Henry M L; O'Dorisio T M; Tesi R J; Ferguson R M; Osei K
Hypoglycemia after successful pancreas transplantation in type I diabetic patients.
Diabetes care 1991;14(11):1111-3.
-
1991: Osei K; Cottrell D A; Orabella M M
Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM.
Diabetes care 1991;14(10):890-6.
-
1991: Osei K; O'Dorisio T M; Malarkey W B; Cataland S
Continuous subcutaneous octreotide infusion: dose-response relationships between metabolic effects and octreotide clearance in patients with insulin-dependent (type 1) diabetes.
The Journal of laboratory and clinical medicine 1991;118(1):56-64.
-
1991: Osei K; Cottrell D A; Bossetti B
Relationships of obesity indices to serum insulin and lipoproteins in relatives of black patients with noninsulin-dependent diabetes mellitus (NIDDM).
International journal of obesity 1991;15(7):441-51.
-
1991: Bello F; Falko J M; O'Dorisio T M; Osei K
The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1991;8(4):385-7.
-
1990: Osei K; Henry M L; O'Dorisio T M; Tesi R J; Sommer B G; Ferguson R M
Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients.
Diabetes 1990;39(10):1235-42.
-
1990: Osei K
Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients with NIDDM.
Diabetes 1990;39(5):597-601.
-
1989: Osei K
Defective insulin-mediated splanchnic glucose regulation and glucose clearance: early glucose homeostatic defects in nondiabetic, young offspring of patients with noninsulin-dependent diabetes mellitus.
Diabetes research (Edinburgh, Scotland) 1989;12(1):7-13.
-
1989: Osei K; Bossetti B
Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(6):506-11.
-
1989: Osei K; O'Dorisio T M; Malarkey W B; Craig E L; Cataland S
Metabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy.
Diabetes 1989;38(6):704-9.
-
1987: Osei K; Holland G C
Clinical correlates of basal hepatic glucose output and metabolic clearance rate of glucose using glucose-C-peptide-body mass indexes in ambulatory type 2 diabetic patients.
Diabetes research (Edinburgh, Scotland) 1987;5(4):181-7.
-
1987: Osei K; Falko J; Bossetti B M; Holland G C
Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes.
The American journal of medicine 1987;83(2):249-55.
-
1987: Osei K; Holland G C
Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients.
Metabolism: clinical and experimental 1987;36(2):122-7.
-
1986: Osei K; Falko J M; Fields P G; Bossetti B; O'Dorisio T M
The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients.
Diabetologia 1986;29(2):100-5.
-
1986: Osei K; Falko J M; O'Dorisio T M; Fields P G; Bossetti B
Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
The Journal of clinical endocrinology and metabolism 1986;62(2):325-30.
-
1985: Osei K; Falko J M; O'Dorisio T M; Adam D R
Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism.
Diabetes care 1985;8(5):436-9.
-
1985: Osei K; Fields P G; Cataland S; Craig E L; George J M; O'Dorisio T M
Abnormal retinal artery responses to stress in patients with type I diabetes.
The American journal of medicine 1985;78(4):595-601.
-
1984: Osei K; Falko J M; O'Dorisio T M; Adam D R
Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients.
Diabetes care 1984;7(5):471-5.
-
1984: Osei K; Falko J M; O'Dorisio T M; Adam D R; Cataland S
Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients.
Diabetes care 1984;7(5):442-6.
Sign-in to see more